Objectives and Implementation

The main objectives of NanoAthero project are the following:

  • Development of biodegradable Nanoparticles with anti-inflammatory and anti-oxidants for targeted treatment of vulnerable plaques.

  • Construction of an innovative in-vitro atherosclerotic model using a bioreactor system.

  • Toxicological tests and preclinical studies of nanoparticles for application in clinical studies.

 

Work Plan

 

Co - financed by the European Union and Greek national funds through the Operational Programme “Competitiveness, Entrepreneurship and Innovation”, under the call “RESEARCH-CREATE-INNOVATE” (project code: Τ2ΕΔΚ-00563)

Project Information

Code: Τ2ΕΔΚ-00563

Acronym: NanoAthero

Full Title: Development and Preclinical Validation of biofunctionalized Nanoparticles for targeted delivery of anti-oxidant factors to treat Atherosclerosis

Duration: 2020 - 2022

©2022 NanoAthero Project. All Rights Reserved.